StockData
NRX Pharmaceuticals, Inc. logo

NRX Pharmaceuticals, Inc. (NRXP) stock

NRXPNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 0/30
$2.45+0.30 (+13.95%)

Close on Nov 17, 2026Market cap $106.08MP/E –Yield –

NRX Pharmaceuticals profit margin

Profit margin (net margin) is net income as a percentage of revenue.

NRX Pharmaceuticals's profit margin for the twelve months ending Jun 30, 2026 was -691.8%. For fiscal 2025 it was -2336.5%.

Annual profit margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 2025-2336.5%–

Quarterly profit margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q2 FY2026Jun 30, 2026-1500.5%–
Q1 FY2026Mar 31, 2026-133.9%–
Q4 FY2025Dec 31, 202536.6%–
Q3 FY2025Sep 30, 2025-2433.9%–

More NRX Pharmaceuticals figures

See a number that looks wrong?